clinical trial · NCT07321899
Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation
Medtronic Cardiovascular·N/A·not yet recruiting·n = 1,186
Severe Tricuspid RegurgitationMedtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) SystemEdwards EVOQUE Tricuspid Valve Replacement (TTVR) System
brief summary
This clinical trial evaluates the safety and effectiveness of the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in symptomatic patients with severe or greater tricuspid regurgitation.
started
Jun 1, 2026
primary completion
Sep 1, 2031
completion
Apr 1, 2041
last updated
Jan 8, 2026
detailed description
Prospective, global, pre-market, interventional, multi-center, randomized controlled pivotal trial to evaluate the safety and effectiveness of the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System compared to Edwards EVOQUE TTVR System in symptomatic patients with severe or greater tricuspid regurgitation.
official title
Transcatheter Tricuspid Valve Replacement Using the Medtronic Intrepid™ TTVR System in Patients With Severe Symptomatic Tricuspid Regurgitation - PATHFINDER
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol